-+ 0.00%
-+ 0.00%
-+ 0.00%

LARIMAR THERAPEUTICS - NOMLABOFUSP U.S. APPROVAL TARGETED FOR MID-2027

Reuters·11/09/2026 21:43:42

Please log in to view news